Target
Pituitary adenylate cyclase-activating polypeptide
Ligand
BDBM50250019
Substrate
n/a
Ki
0.1±n/a nM
Comments
PDSP_2377
Citation
 Ciccarelli, ESvoboda, MDe Neef, PDi Paolo, EBollen, ADubeaux, CVilardaga, JPWaelbroeck, MRobberecht, P Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells. Eur J Pharmacol 288:259-67 (1995) [PubMed]  Article 
Target
Name:
Pituitary adenylate cyclase-activating polypeptide
Synonyms:
Adcyap1 | PACAP | PACAP-27 | PACAP-38 | PACA_RAT | Pituitary adenylate cyclase-activating polypeptide
Type:
Enzyme Catalytic Domain
Mol. Mass.:
19565.66
Organism:
RAT
Description:
PACAP 0 RAT::P13589
Residue:
175
Sequence:
MTMCSGARLALLVYGIIMHNSVSCSPAAGLSFPGIRPEEEAYDQDGNPLQDFYDWDPPGAGSPASALRDAYALYYPADRRDVAHEILNEAYRKVLDQLSARKYLQSMVARGMGENLAAAAVDDRAPLTKRHSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNKGRRIAYL
  
Inhibitor
Name:
BDBM50250019
Synonyms:
CHEMBL524658 | PACAP | PACAP(1-38) | PACAP-38 | PACAP38
Type:
Small organic molecule
Emp. Form.:
C203H331N63O53S
Mol. Mass.:
4534.256
SMILES:
n/a
Structure:
Search PDB for entries with ligand similarity: